Co-Authors
This is a "connection" page, showing publications co-authored by Wan Park and Taek Kim.
Connection Strength
0.388
-
Evidence of Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection After Recovery from Mild Coronavirus Disease 2019. Clin Infect Dis. 2021 11 02; 73(9):e3002-e3008.
Score: 0.061
-
Longitudinal proteomic profiling provides insights into host response and proteome dynamics in COVID-19 progression. Proteomics. 2021 06; 21(11-12):e2000278.
Score: 0.059
-
Clinical Application of the Standard Q COVID-19 Ag Test for the Detection of SARS-CoV-2 Infection. J Korean Med Sci. 2021 Apr 12; 36(14):e101.
Score: 0.059
-
Communication: Comparison of Respiratory Specimens for the Detection of SARS-CoV-2. Ann Clin Lab Sci. 2021 Jan; 51(1):140-144.
Score: 0.058
-
Compassionate use of hzVSF-v13 in two patients with severe COVID-19. J Med Virol. 2020 11; 92(11):2371-2373.
Score: 0.055
-
In vitro activity of lopinavir/ritonavir and hydroxychloroquine against severe acute respiratory syndrome coronavirus 2 at concentrations achievable by usual doses. Korean J Intern Med. 2020 07; 35(4):782-787.
Score: 0.055
-
Microevolution of Outbreak-Associated Middle East Respiratory Syndrome Coronavirus, South Korea, 2015. Emerg Infect Dis. 2016 Feb; 22(2):327-30.
Score: 0.041